Henry S. Park, MD, MPH (@henryparkmd) 's Twitter Profile
Henry S. Park, MD, MPH

@henryparkmd

Assoc Prof, Vice Chair Clinical Research, Chief Thoracic RT @YaleRadOnc | Asst Med Dir @YaleCancer Clinical Trials Office | Head of Advisory College @YaleMed

ID: 2437465370

linkhttps://medicine.yale.edu/profile/henry-park/ calendar_today10-04-2014 20:04:48

616 Tweet

1,1K Takipçi

474 Takip Edilen

Henry S. Park, MD, MPH (@henryparkmd) 's Twitter Profile Photo
Henry S. Park, MD, MPH
@henryparkmd

23 days ago

I believe there is still equipoise regarding SBRT and immunotherapy. Let’s finish S1914 accrual (87% accrued) in the next few months since the design is quite different (2 cycles of neoadjuvant immunotherapy before SBRT, shorter duration of immunotherapy) and await PAC4 results!